Our data reveal that Gpr125+ cells are expanded in murine mammary tumors arising with reduced tumor latency and that high Gpr125 expression is associated with particularly poor outcomes in basal-type breast cancer. This evidence concerns the gene ADGRA3 and neoplasm.